Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation

Prostaglandin E2 Exerts Catabolic Effects in Osteoarthritis Cartilage: Evidence for Signaling via the EP4 Receptor

(2014) M. Attur et al.   JOURNAL OF IMMUNOLOGY

Sulforaphane protects human chondrocytes against cell death induced by various stimuli

(2010) Annalisa Facchini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention

(2009) Ka Lung Cheung et al.   AAPS Journal

Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate

(2009) Jin-Sun Kong et al.   ARTHRITIS AND RHEUMATISM

Neuroprotective Role of Haptoglobin after Intracerebral Hemorrhage

(2009) X. Zhao et al.   JOURNAL OF NEUROSCIENCE

Biomechanical Thresholds Regulate Inflammation through the NF-κB Pathway: Experiments and Modeling

(2009) Jin Nam et al.   PLoS One

Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes

(2009) H. Ah Kim et al.   RHEUMATOLOGY